Castle Creek Arbitrage’s Envoy Medical COCH Stock Holding History

Castle Creek Arbitrage’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-293,880	Closed	-$2.94M	–	466
2022 Q4	$2.94M	Hold	293,880	–	–	0.26%	114
2022 Q3	$2.89M	Hold	293,880	–	–	0.16%	188
2022 Q2	$2.88M	Hold	293,880	–	–	0.16%	189
2022 Q1	$2.87M	Hold	293,880	–	–	0.14%	195
2021 Q4	$2.86M	Hold	293,880	–	–	0.14%	198
2021 Q3	$2.85M	Hold	293,880	–	–	0.16%	159
2021 Q2	$2.86M	Buy	+293,880	New	+$2.86M	0.16%	164

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Castle Creek Arbitrage's COCH Position: Q1 2023 in Review

Castle Creek Arbitrage sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 293,880 shares — an estimated $2.94M sold.

Castle Creek Arbitrage first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $2.94M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

Castle Creek Arbitrage reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
Castle Creek Arbitrage sold 293,880 Envoy Medical shares in Q1 2023, an estimated $2.94M.
Castle Creek Arbitrage first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
Castle Creek Arbitrage's Envoy Medical position peaked at $2.94M in Q4 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Castle Creek Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.